Search for…

• Innovative 3D cell culture matrix with tunable properties

  B79074

  Innovative 3D cell culture matrix with tunable properties

  • New Matrix for 3D cell culture preparation
  • Cost-effective material with defined material properties
  • Allows free design of culture conditions
• Innovative 18F-labeled Norepinephrine analog PET tracers for broad diagnostic applications in neurology, cardiology and oncology

  B78129

  Innovative 18F-labeled Norepinephrine analog PET tracers for broad diagnostic applications in neurology, cardiology and oncology

  • Simple and low-cost synthesis and superior labeling efficiency
  • Extended tracer half-life and high PET signal strength
  • Widely applicable in neurology, oncology and cardiology
• Tau aggregation inhibiting peptides as a basis for future therapies for tauopathies

  B79054

  Tau aggregation inhibiting peptides as a basis for future therapies for tauopathies

  • Tau aggregation inhibiting peptides
  • Strongly bind to tau monomers, -oligomers and -fibrils
  • Suitable for future tauopathy therapies
• Better together – Novel dual-acting and disease-modifying approach to combat Alzheimer’s

  B79080

  Better together – Novel dual-acting and disease-modifying approach to combat Alzheimer’s

  • Combinatory hybrid approach with disease-modifying properties
  • Strong neuroprotection in in vivo Alzheimer’s model
  • Absence of hepatotoxicity even at high doses
• Superior BChE inhibitors for Alzheimer’s Disease

  B78084

  Superior BChE inhibitors for Alzheimer’s Disease

  • Highly potent BChE inhibitors
  • BChE inhibitors with neuroprotectant properties
  • Long and controllable duration of action
• Amyloid Inhibitory Peptides for Alzheimer’s Disease and Diabetes

  B78094

  Amyloid Inhibitory Peptides for Alzheimer’s Disease and Diabetes

  • macrocyclic peptides (MCIPs): novel class of nanomolar amyloid inhibitors of both Aβ40(42) and IAPP or of Aβ40(42) alone
  • candidates/leads for macrocyclic peptide‐based anti‐amyloid drugs
  • scaffolds for the design of small‐molecule peptidomimetics for targeting amyloidogenesis
• New drug target in Alzheimer’s disease

  B74174

  New drug target in Alzheimer’s disease

  • Aη-α as a new drug target and / or diagnostic marker for Alzheimer’s disease
  • Inhibition of β-secretase leads to accumulation of Aη-α
  • Antibodies to detect η-secretase pathway peptides are available

7 of 106 Tech Offers